Accretion Nutraveda IPO Subscription
The Accretion Nutraveda IPO subscription reflects the demand received from different investor categories during the bidding period. The subscription data includes the number of shares offered, shares bid for, and the subscription multiple (X) for categories such as Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), and Retail Individual Investors (RIIs).
As per the latest subscription update, the Accretion Nutraveda IPO has received bids for 24,40,000 shares against 12,80,000 shares offered, resulting in an overall subscription of 1.91x. the NII category is subscribed 2.42x, Retail Investors 2.19x, and QIBs 1.01x.
Subscription Highlights
- Overall Subscription: 1.91x
- QIB Subscription: 1.01x
- NII Subscription: 2.42x
- Retail Subscription: 2.19x
- Retail
- 2.19x
- NII
- 2.42x
- QIB
- 1.01x
- Total
- 1.91x
Current GMP
₹68 (+52.71%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
Accretion Nutraveda IPO Subscription Details ( Fri, 30 Jan 26 01:59 PM)
| Category | Shares Offered | Shares Bid For | Subscription (x) |
|---|---|---|---|
| Qualified Institutions | 364,000 | 367,000 | 1.01x |
| Non-Institutional | 276,000 | 669,000 | 2.42x |
| Retail Investors | 640,000 | 1,404,000 | 2.19x |
| Total | 1,280,000 | 2,440,000 | 1.91x |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Application Wise Breakup (Approximate)
| Category | Reserved | Applied | Times (x) |
|---|---|---|---|
| Non-Institutional | - | 107 | - |
| Retail Investors | - | 702 | - |
Subscription figures are updated periodically and may change until issue closing. Data reflects bids placed across exchanges.
Shares bids Against Offered
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Where Can I Check the Accretion Nutraveda IPO Live Subscription Status?
You can check the Accretion Nutraveda IPO live subscription status on the IPO Master App or the official websites of the BSE. The live subscription data is updated regularly during the IPO bidding period and displays category-wise subscription figures for Retail Individual Investors (RII), Non-Institutional Investors (NII), Qualified Institutional Buyers (QIB), Employees (if applicable), and the overall IPO subscription.
What is Accretion Nutraveda IPO retail subscription status?
The Retail Individual Investor (RII) portion of the Accretion Nutraveda IPO was subscribed 2.19 times as of Fri, Jan 30, 2026 07:29 PM. The public issue closed on Fri, Jan 30, 2026 for bidding.
How to subscribe Accretion Nutraveda IPO?
Investors can apply for the Accretion Nutraveda IPO online through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or via UPI using a SEBI-registered stockbroker or trading app. Select the desired lot size, enter your bid within the price band, and submit your application during the IPO subscription period. The application amount remains blocked in your bank account until the IPO allotment process is completed.
How many times Accretion Nutraveda IPO subscribed?
The Accretion Nutraveda IPO was subscribed 1.91x times at the close of bidding period on Fri, Jan 30, 2026.
How to check Accretion Nutraveda IPO allotment?
The Accretion Nutraveda IPO allotment was finalized on Mon, Feb 2, 2026. You can check the Accretion Nutraveda IPO allotment status on the registrar's website or the BSE/NSE websites using your PAN, application number, or DP/Client ID. You can also check the allotment status quickly through the IPO Master App.
When Will the Accretion Nutraveda IPO Be Listed?
The Accretion Nutraveda IPO was listed on Wed, Feb 4, 2026, on the BSE.
What is the Accretion Nutraveda IPO Qualified Institutional Buyers (QIB) subscription status?
The Qualified Institutional Buyers (QIB) category of Accretion Nutraveda IPO was subscribed 1.01 times as of Fri, Jan 30, 2026 07:29 PM.